Brief: Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
14/03/2023 12:58
March 14 (Reuters) - Adamis Pharmaceuticals Corp
ADMP.O :
* ADAMIS PHARMACEUTICALS ANNOUNCES $3.0 MILLION REGISTERED
DIRECT
OFFERING
Source text for Eikon: ID:nGNX8ZN1Bd
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update